Work

Figure S1 from Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy

Year: 2023

Type: other

Abstract: The antitumor effects of anti-CTLA-4 mAbs were dependent on tumor cell-derived IL-33

DOI: 10.1158/2326-6066.22543735

Authors: Lujun Chen, Runzi Sun, Junchi Xu, Wensi Zhai, Dachuan Zhang, Min Yang, Cuihua Yue, Yichao Chen, Song Li, Heth Turnquist, Jingting Jiang, Binfeng Lu

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362629614

Cites:

Cited by:

Related to: 10